ArticleFrontiers in immunology2025

Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study.

Haijuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.